Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 3NIH 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Sarcoma 2Lymphoid 2

Conditions

Sarcoma 168Gliosarcoma 134Glioblastoma 130Brain Neoplasms 101Astrocytoma 86Central Nervous System Neoplasms 77Osteosarcoma 65Oligodendroglioma 61Neuroblastoma 58Sarcoma, Kaposi 56Glioma 51Neuroectodermal Tumors, Primitive, Peripheral 48Dendritic Cell Sarcoma, Interdigitating 44Burkitt Lymphoma 44Rhabdomyosarcoma 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 41Neoplasms 40Lymphoma 39Wilms Tumor 37Medulloblastoma 35Lymphoma, Non-Hodgkin 35Recurrence 32Sarcoma, Ewing 31Acquired Immunodeficiency Syndrome 30Lymphoma, Large B-Cell, Diffuse 29HIV Infections 29Ependymoma 28Leukemia 27Gastrointestinal Stromal Tumors 27Melanoma 26

Interventions

tocilizumab 1Zidovudine 1Valganciclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Castleman Disease × Sarcoma × Clear all
NCT03300830 2026-05-29

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

National Institutes of Health Clinical Center (CC)

Recruiting
280 enrolled
LymphoidSarcoma

Acquired Immunodeficiency Syndrome, Castleman Disease, Immunologic Deficiency Syndromes, Sarcoma, Kaposi

NCT01441063 2020-10-27

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
8 enrolled 18 charts
LymphoidSarcoma

Multi-centric Castleman's Disease, Acquired Immunodeficiency Syndrome, Castleman Disease, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon âš¡